Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks, bar. That means a lot to me.
Perhaps. I recall the suggested time frame to be 3-6 months from the last interview, and Seamus did express the possibility of contingencies and whatnot. It's a lot of work to spin off a company, and as we all know, he's up to ass in work right now. So, we'll see. Another consideration--admittedly, based on this morning's rumor--is that if a leveraged buyout were to transpire, that potential spinoff may be held as an asset, potentially disrupting the number of free shares or free shares at all. Of course, there's no guarantee of that and we'd have to see where the control ultimately lies. Again, speculation is based on a rumor of a potential leveraged buyout.
I want to say it was 1 for 300, but I can't be sure. It was considered a dividend and I actually still have the cert. I haven't looked at the stock in a decade, since I only own a few hundred shares. HRCT eventually went bankrupt, but I was out by then. Now I'm curious. Gonna have to see if Elephant Talk is still around.
I have. Hartcourt Companies HRCT gave away shares of its Elephant Talk spin off in about 1999. Both were OTC, but it's rare and even rarer nowadays.
10K Worriers: You're assuming the company has not filed their 10K, but the truth is you don't know that. There is an Acceptance date, and a Filing Date. If the Acceptance date was yesterday at around close of business, then it stands to reason the filing date will be some time today, after the filing is processed. So, by all means, complain until you're blue in the face, it will help us cool folks recognize you when the filing suddenly appears.
I fail to understand why the investment community increasingly lacks patience and fortitude. I mean, I get it if they're young, because the kids these days are reliant on instant gratification. But it seems like nearly everyone is cliffside with their emotions and a case of severe diarrhea. Nobody can just take a breath and trust their judgement, rather they question themselves and everything around them, which quickly turns to fear and accusation. Then they jump. I miss the days when people had conviction, integrity, and self-confidence. It's getting harder to be successful in the long position with what is amounting to too much volatility. I never thought I'd say a stock could be too volatile, especially an OTC stock. So weird. And there's nothing I or anyone else can do but find ways to adapt to the mass injection of human fear into the markets. Even MM's and other institutional players have had to adapt, and of course they constitute a force in the markets. What's unfortunate is that those players have adapted into blood suckers, bleeding everything they can in an effort to meet those annual goal increases so that shareholders feel fatter even though it's only executives getting fatter. Our economic perspective has somehow shifted from quality to quantity, creating a mirage for investors who focus on year-end gains reports vs. a company's contribution to society. Pitiful, and because we as a whole measure ourselves by our financial well being, we continue down this path of narrow-mindedness and short-sightedness.
Just because it hasn't been posted doesn't mean it hasn't been filed.
But not beer money.
Wal-Mart started on the OTC.
MM's don't necessarily have so much control that they can put the price where they want it. It's not that direct. Instead, they use proven tactics that feed into the fear of investors, causing results in line with their needs. They can put up false walls to give the appearance of selling pressure, as well as false bids to give the appearance of buying pressure, etc. Emotional investors eat that shit up like candy from their grandmother. BUT! There is always a system of checks and balances in any numbers game. As I stated earlier today, what a MM does in the minute, he will answer for in the hour, which is an analogy to say that everything will eventually reconcile, it's the nature of mathematics. Buy now, pay later. It always has to equalize. It's only a matter of time. MM's can create enough fear to get them through the moment or a trading period, but that means when things come back around, those in the neutral position stand to gain if they have lost, even if only on paper. Same works in reverse. It's all a game of credits and debits that in an undefined timeline have to reconcile. Flippers narrow their timeline for natural correction, thereby either losing money or gaining money in the short term. Their losses are our gains, but you have to let the balances come into play by remaining within the timeline. That's the way I see it.
Funny thing about debits and credits, they have to reconcile eventually. No matter what MM's do in the minute, the hour awaits them.
Haha, yes!
I sport a nice patina, so no polish here.
If we get to .10+ by May 1st, I will strongly consider changing my AS and compensation votes to yes.
They can't change the record date without starting the whole process over again. That's like selecting a new jury after deliberation.
RENNOVA HEALTH POSTPONES SPECIAL MEETING OF STOCKHOLDERS TO MAY 2, 2018 WEST PALM BEACH, Fla, April 17, 2018 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that recently announced the acquisition of its second Rural Hospital, today announces the postponement of its Special Meeting of Stockholders to May 2, 2018 at 11:00 a.m. Eastern time at the offices of Shutts & Bowen LLP, 525 Okeechobee Boulevard, Suite 1100, West Palm Beach, FL 33401. The record date of March 12, 2018 remains unchanged. This Special Meeting was originally scheduled for April 18, 2018. "Stockholder approval of the proposed increase in authorized common shares plus the ability to enact a reverse stock split is critical for the company going forward," stated Seamus Lagan, President and Chief Executive Officer of Rennova adding "Should any of the company's convertible debt or preferred stock holders elect to exercise or convert their shares, the company currently does not have sufficient shares to meet those obligations." "The agreements under which many of the convertible debt and preferred stock securities were issued require the company to seek an increase in the number of authorized shares of common stock to accommodate all of the possible issuances," noted Mr. Lagan. If you have already voted and wish to change your vote or if you are ready to vote your shares now, please call our proxy solicitor, Advantage Proxy toll free at 1-877-870-8565 for assistance. The Special Meeting is for the following purposes: 1. To approve an amendment to our certificate of incorporation, as amended, to effect a reverse stock split of all of the outstanding shares of our common stock, par value $0.01 per share, at a specific ratio within a range of 1-for-50 to 1-for-300, and to grant authorization to our Board of Directors to determine, in its discretion, the specific ratio and timing of the reverse stock split any time before March 1, 2019, subject to the Board of Directors' discretion to abandon such amendment; 2. To approve an amendment to our certificate of incorporation, as amended, to increase the number of authorized shares of our common stock from 500,000,000 to 3,000,000,000 shares; 3. To approve the Company's new 2018 Incentive Award Plan; 4. To authorize an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes in favor of Proposals 1, 2 and 3; and 5. To transact such other business as may properly come before the Special Meeting or any adjournment or postponement thereof.
And in the meantime, I expect inevitable good news!
Excellent indeed! Another cog in the wheel.
Sounds like a children's book.
I suppose you're the author.
Nice. I'll see your Patience and raise you this...
News
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--April 17, 2018-- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box(R) , today announced that it has successfully completed a "multiple course ifosfamide study" required by the U.S. Food and Drug Administration (FDA). In the two earlier clinical trials using PharmaCyte's encapsulation technology, Cell-in-a-Box(R) plus low doses of ifosfamide, only two courses of ifosfamide treatment were given to the patients. As part of PharmaCyte's Investigational New Drug Application (IND), the FDA required PharmaCyte to provide data showing that the encapsulated cells PharmaCyte plans to use for its clinical trial in patients with locally advanced, non-metastatic, inoperable pancreatic cancer (LAPC) are still alive and capable of converting the prodrug ifosfamide to its cancer killing form after multiple courses of ifosfamide are administered. To provide the information required by the FDA, a series of in vitro experiments were performed with unfrozen encapsulated ifosfamide-activating cells in culture that were treated with successive courses of ifosfamide over many days. This extensive testing that was done to demonstrate the ifosfamide activating cells inside the Cell-in-a-Box(R) capsules can withstand multiple courses of ifosfamide administration has now been completed. The results show that the cells continue to activate ifosfamide to its cancer killing metabolite without themselves being damaged. PharmaCyte's Chief Executive Officer, Kenneth L. Waggoner, explained the significance of the successful study saying, "PharmaCyte's treatment for LAPC utilizes cells that produce a particularly potent cytochrome P450 enzyme that is able to activate ifosfamide. These cells are encapsulated in the Cell-in-a-Box(R) technology, and the capsules are implanted near the cancerous tumor so that a high local concentration of the cancer killing, short-lived ifosfamide metabolite is produced near the tumor. Unlike the earlier two clinical trials, in our upcoming trial using the same cell-based therapy, we will be giving multiple doses of ifosfamide. We are extremely pleased that the final data from this study is positive and allows us to continue our forward momentum to filing our IND." Ifosfamide is a chemotherapeutic agent that is routinely used to treat a variety of cancers, including testicular cancer and non-Hodgkin's lymphoma. Because ifosfamide is a prodrug, by itself it is not toxic to cancer cells. Ifosfamide must be activated by cytochrome P450 enzymes such as those found in the cells to be used in into a short-lived intermediate form that can enter tumor cells and kill them. Since the capsules are filled with ifosfamide-activating cells that are alive but are no longer dividing and the cell-killing effect is limited to cells that can multiply (such as those growing in a cancerous tumor); this forms the basis for the tumor selectivity of ifosfamide in PharmaCyte's upcoming trial in patients with LAPC.
Haha, awesome. I'd recommend as part of your takeaway, that this particular play is extremely rare and may be played the way you are playing it. Almost all of your other plays will be played the way most people are playing RNVA, for the instant gratification; seize the hour, seize the day, or seize the swing. That's where 90%+ of your gains (and losses) come from. The other 9.9% comes from those inevitable attachment stocks, the one's that you either decided not to take a loss on and average down because you 'believe' in the company. Be careful with those. But you and I are in that .1% situation, which doesn't happen often and never happens the same way twice. It's a spin of the wheel, and all of your marbles are on the table, brass ones not withstanding. GL
RE: R/S potential.
The way I see it, it's a bet. Either you take the bet, or you don't. If the vote were to pass, and they affect a R/S, then it kills the run because the upside potential is, well, divided by the denominator of the split. If that happens, naturally, people will sell because there's no more exponential upside potential. On the flipside, if it doesn't pass or is abandoned, the recognizable upside potential will become realized, partially immediately. It's very simple. This stock will either R/S and experience a decline, seeing those who held (me) lose a few bucks before they can vacate their positions, or, this stock will make many hundred thousand-aires and probably many millionaires.
The bottom line for my decision is that these opportunities to place such a bet don't come along often. I'm willing to lose a couple thousand dollars in a game of fifty-fifty. Hell yeah, I am. Best of luck to those who are putting their money on black.
I here ya! 2/27 and haven't parted with a single share.
You see no such thing. The vote isn't until April 18th.
You know it's low if I almost bought the dip, lol. I take my position and either hold or sell from there. I damned near bought that dip, lol. This stock is just fine. We achieved today, what I thought would take two days. I'm focused on the daily chart at this point. Intra-day garble means nothing to me.
LOL, no doubt.
Haha, this is why it's important to know the difference between your and you're. Best post today.
Haha.
Northern Michigan
Soggy? I wish. We got a foot of snow over the weekend and they're calling for another 3-6" today. I hope RNVA is a ray of light today, lol.
Boy did they! Three tiers. It was amazing to watch. I always get excited by the beauty of mass chaos. We need all kinds in this world, and we have them.
Undaunted.
ASCM in the shadows now.
Easy, Tiger. Are you better now?
Let them earn their karma. In the end, only fearful sellers will lose money.
ASCM swallowing it whole.
Fess up! Who sold that dip or got stopped out? lol
Now we churn.
Strength indicator: still trading in the upper half of the 30 minute channel after all of those transactions. That's a bad-ass trend, right there.